OncoSec Medical (ONCSQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock ONCSQ vs. EFTR, PXMD, ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, and BTMDWShould you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include eFFECTOR Therapeutics (EFTR), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry. OncoSec Medical vs. Its Competitors eFFECTOR Therapeutics PaxMedica 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote eFFECTOR Therapeutics (NASDAQ:EFTR) and OncoSec Medical (NASDAQ:ONCSQ) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends. Which has more risk & volatility, EFTR or ONCSQ? eFFECTOR Therapeutics has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, OncoSec Medical has a beta of -19.7, suggesting that its share price is 2,070% less volatile than the S&P 500. Is EFTR or ONCSQ more profitable? Company Net Margins Return on Equity Return on Assets eFFECTOR TherapeuticsN/A N/A N/A OncoSec Medical N/A N/A N/A Does the media refer more to EFTR or ONCSQ? In the previous week, eFFECTOR Therapeutics' average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score. Company Overall Sentiment eFFECTOR Therapeutics Neutral OncoSec Medical Neutral Which has better earnings & valuation, EFTR or ONCSQ? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioeFFECTOR TherapeuticsN/AN/A-$35.81M-$13.080.00OncoSec MedicalN/AN/A-$34.18MN/AN/A Do institutionals & insiders have more ownership in EFTR or ONCSQ? 57.7% of eFFECTOR Therapeutics shares are owned by institutional investors. 4.7% of eFFECTOR Therapeutics shares are owned by company insiders. Comparatively, 1.3% of OncoSec Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryeFFECTOR Therapeutics beats OncoSec Medical on 3 of the 4 factors compared between the two stocks. Get OncoSec Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONCSQ vs. The Competition Export to ExcelMetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$817.60M$5.55B$9.40BDividend YieldN/A4.84%3.75%4.03%P/E RatioN/A1.4128.0119.82Price / SalesN/A27.13432.8198.20Price / CashN/A19.5636.1658.27Price / BookN/A6.878.125.65Net Income-$34.18M-$4.17M$3.25B$257.91M OncoSec Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCSQOncoSec MedicalN/AN/AN/AN/A$1KN/A0.0040EFTReFFECTOR Therapeutics0.0726 of 5 stars$0.00flatN/A-99.6%$1KN/A0.0010PXMDPaxMedicaN/AN/AN/AN/A$1KN/A0.002ATNFW180 Life SciencesN/A$0.01-6.3%N/A-15.6%$0.00N/A0.007LBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.00flatN/AN/A$0.00N/A0.002Gap DownAIMDWAinosN/A$0.14+16.8%N/AN/A$0.00$106.21K0.0040ALVOWAlvotechN/A$1.59-3.6%N/A-33.7%$0.00$585.60M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.04+75.5%N/AN/A$0.00N/A0.0015BFRIWBiofronteraN/A$0.10-11.4%N/A+99.8%$0.00$38.00M0.0070Gap DownBTMDWbioteN/A$0.01+20.0%N/A-97.3%$0.00$199.38M0.00N/A Related Companies and Tools Related Companies eFFECTOR Therapeutics Alternatives PaxMedica Alternatives 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONCSQ) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSec Medical Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoSec Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.